Rozerem Approval History
- FDA approved: Yes (First approved July 22nd, 2005)
- Brand name: Rozerem
- Generic name: ramelteon
- Company: Takeda Pharmaceuticals North America, Inc.
- Treatment for: Insomnia
Rozerem (ramelteon) is an orally active hypnotic indicated for the treatment of insomnia characterized by difficulty with sleep onset.
Development History and FDA Approval Process for Rozerem
|Jul 22, 2005||Rozerem Takeda Pharmaceuticals North America, Inc. - Treatment for Insomnia|
|Sep 24, 2004||Takeda Submits New Drug Application for Ramelteon, an Investigational Sleep Drug|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.